These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29762761)

  • 1. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex.
    Tuon FF; Florencio KL; Rocha JL
    Med Mycol; 2019 Apr; 57(3):265-269. PubMed ID: 29762761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
    Falci DR; da Rosa FB; Pasqualotto AC
    Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
    Yang H; Chaudhari P; Zhou ZY; Wu EQ; Patel C; Horn DL
    Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
    Merry M; Boulware DR
    Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK; Graybill JR; Johnson ES; Hausrath SG; Pollard RB; Kolokathis A; Mildvan D; Fan-Havard P; Eng RH; Patterson TF; Pottage JC; Simberkoff MS; Wolf J; Meyer RD; Gupta R; Lee LW; Gordon DS
    Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
    Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation.
    Umemura K; Katada Y; Nakagawa S; Hira D; Yutaka Y; Tanaka S; Ohsumi A; Nakajima D; Date H; Nagao M; Terada T
    J Infect Chemother; 2024 Aug; 30(8):741-745. PubMed ID: 38354908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactions.
    Horwitz E; Shavit O; Shouval R; Hoffman A; Shapiro M; Moses AE
    Int J Clin Pharm; 2012 Aug; 34(4):611-7. PubMed ID: 22674178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
    Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of amphotericin B lipid complex.
    Luke RG; Boyle JA
    Am J Kidney Dis; 1998 May; 31(5):780-5. PubMed ID: 9590187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis.
    Perfect JR; Wright KA
    J Antimicrob Chemother; 1994 Jan; 33(1):73-81. PubMed ID: 8157577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
    Zhao T; Xu X; Wu Y; Zhang W; Zeng Q; Lu Y; Yang T; Zhou G; Yu J; Lan K; Harypursat V; Chen Y
    BMC Infect Dis; 2022 Aug; 22(1):677. PubMed ID: 35941618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature.
    Martino R
    Curr Med Res Opin; 2004 Apr; 20(4):485-504. PubMed ID: 15119986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients.
    Torre D; Banfi G; Tambini R; Speranza F; Zeroli C; Martegani R; Airoldi M; Fiori G
    J Infect; 1998 Jul; 37(1):36-8. PubMed ID: 9733375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.